Neuramate en es it fr

Neuramate Brand names, Neuramate Analogs

Neuramate Brand Names Mixture

  • No information avaliable

Neuramate Chemical_Formula


Neuramate RX_link

No information avaliable

Neuramate fda sheet

Neuramate msds (material safety sheet)

Neuramate Synthesis Reference

No information avaliable

Neuramate Molecular Weight

309.469 g/mol

Neuramate Melting Point

< 25 oC

Neuramate H2O Solubility

Soluble as HCl salt

Neuramate State


Neuramate LogP


Neuramate Dosage Forms

Tablets (oral, 1 mg)

Neuramate Indication

Used for the symptomatic treatment of parkinsonism.

Neuramate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Neuramate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Neuramate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Neuramate Patient Information

Neuramate Organisms Affected

Humans and other mammals